Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo wireless esophageal pH monitoring study
Background: Patients with gastroesophageal reflux disease (GERD) are treated with proton pump inhibitors (PPIs). Those that do not achieve symptom relief, or non-responders, usually undergo esophageal pH monitoring off PPIs in order to confirm the presence of GERD. Aims: To assess the efficacy of th...
Main Authors: | R. Schey, S.P. Alla, D. Midani, H.P. Parkman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-10-01
|
Series: | Revista de Gastroenterología de México (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2255534X17300622 |
Similar Items
-
Recurrencia sintomática relacionada con la enfermedad por reflujo gastroesofágico en pacientes que descontinúan los inhibidores de la bomba de protones durante el estudio inalámbrico de monitorización de pH esofágico Bravo®
by: R. Schey, et al.
Published: (2017-10-01) -
The assessment of patients with non-erosive gastroesophageal reflux disease by using the Bravo® pH monitoring system
by: Gök Mehmet, et al.
Published: (2022-09-01) -
Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
by: Yi-Chao Shi, et al.
Published: (2019-02-01) -
Options for optimizing treatment of gastroesophageal reflux disease with proton pump inhibitors
by: M. F. Osipenko, et al.
Published: (2015-12-01) -
Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
by: Reidar Fossmark, et al.
Published: (2023-09-01)